Last reviewed · How we verify
Cholecalciferol 25000 IU orally every 2 weeks — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Cholecalciferol 25000 IU orally every 2 weeks (Cholecalciferol 25000 IU orally every 2 weeks) — King Faisal Specialist Hospital & Research Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Cholecalciferol 25000 IU orally every 2 weeks TARGET | Cholecalciferol 25000 IU orally every 2 weeks | King Faisal Specialist Hospital & Research Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Cholecalciferol 25000 IU orally every 2 weeks CI watch — RSS
- Cholecalciferol 25000 IU orally every 2 weeks CI watch — Atom
- Cholecalciferol 25000 IU orally every 2 weeks CI watch — JSON
- Cholecalciferol 25000 IU orally every 2 weeks alone — RSS
Cite this brief
Drug Landscape (2026). Cholecalciferol 25000 IU orally every 2 weeks — Competitive Intelligence Brief. https://druglandscape.com/ci/cholecalciferol-25000-iu-orally-every-2-weeks. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab